SUPRAVALVULAR AORTIC STENOSIS

This adverse event was reported 28 times

These drugs are most commonly taken by patients reporting SUPRAVALVULAR AORTIC STENOSIS:

# Drug Count
0 CLOPIDOGREL BISULFATE 12
1 RAMIPRIL 12
2 ACETYLSALICYLIC ACID 9
3 CLOPIDOGREL 9
4 METOPROLOL 9
5 METOPROLOL TARTRATE 9
6 PAROXETINE HYDROCHLORIDE 5
7 PRAVASTATIN SODIUM 3
8 ASPIRIN 2
9 ASPIRIN 325 MG 2
See all common drugs associated with SUPRAVALVULAR AORTIC STENOSIS

SUPRAVALVULAR AORTIC STENOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SEBELIPASE ALFA 1 0.0025
1 FLUORESCEIN SODIUM 1 0.0025
2 PHENYLEPHRINE HCL 1 0.0014
3 TROPICAMIDE 1 0.0011
4 SENNOSIDES AND DOCUSATE SODIUM 1 0.0007
5 LEVALBUTEROL TARTRATE 1 0.0007
6 HYPROMELLOSE 1 0.0004
7 POTASSIUM CITRATE 1 0.0004
8 POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL 1 0.0003
9 DOCUSATE SODIUM AND SENNOSIDES 1 0.0002
See all drugs enriched for association with SUPRAVALVULAR AORTIC STENOSIS

These drug classes are most commonly taken by patients reporting SUPRAVALVULAR AORTIC STENOSIS:

# Drug class Count
0 Angiotensin Converting Enzyme Inhibitor [EPC] 12
1 Insulin Analog [EPC] 1
See all common drug classes associated with SUPRAVALVULAR AORTIC STENOSIS

SUPRAVALVULAR AORTIC STENOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Angiotensin Converting Enzyme Inhibitor [EPC] 12 0.0001
1 Insulin Analog [EPC] 1 0.0000
See all drug classes enriched for association with SUPRAVALVULAR AORTIC STENOSIS